CIHR funds study’s fight against antimicrobial resistance
CIHR has approved a total of $300,000 in funding for three projects addressing the global threat of antimicrobial resistance and fostering collaboration between key players in the field.
Antimicrobial resistance (AMR) has been identified as a global health threat, reducing the ability of health-care providers to control infectious disease. The phenomenon occurs when microbes – bacteria, viruses, fungi and parasites - change and can no longer be kept in check by traditional drugs.
Faculty of Medicine researcher Ronald Labonté, professor in the School of Epidemiology and Public Health, is the recipient of $100,000 for his study aiming to indentify research gaps in global governance arrangements, structures, and institutions addressing AMR and related infectious disease threats. The study also intends to develop an interdisciplinary Canadian network of researchers, scholars, and knowledge users in the global governance of AMR.
In addition to principal investigator Dr. Labonté, the grant network also includes uOttawa representation from The Ottawa Hospital (Dr. Kumanan Wilson, as a co-applicant on the grant), the Faculty of Health Sciences (professor Tracey O’Sullivan, as a collaborator) and the Faculty of Law (professor Colleen Flood, also as a collaborator).
Read the news release from CIHR.